Molecule.one Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1M

  • Investors
  • 16

Molecule.one General Information

Description

Developer of an artificial intelligence platform designed for autonomous drug discovery. The company offers an artificial intelligence platform that combines frontier chemistry models with high-throughput experimentation and proprietary data, enabling pharmaceutical researchers to automate synthesis planning, predict reaction outcomes, and discover new chemical reactions for drug manufacturing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4370 Alpine Road
  • Suite 104
  • Portola Valley, CA 94028
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Corporate Office
  • 4370 Alpine Road
  • Suite 104
  • Portola Valley, CA 94028
  • United States

Molecule.one Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Molecule.one Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 11-Jun-2025 $1M Completed Generating Revenue
5. Later Stage VC 01-Jan-2024 Completed Generating Revenue
4. Later Stage VC (Series A) 04-May-2021 Completed Generating Revenue
3. Accelerator/Incubator 23-Oct-2020 Completed Generating Revenue
2. Seed Round 07-Aug-2019 $58.9K $58.9K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Molecule.one’s complete valuation and funding history, request access »

Molecule.one Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed-3
Seed-2 490,572 $0.000100 $0.17 $0.17 1x $0.17 3.97%
Seed-1 471,715 $0.000100 $0.18 $0.18 1x $0.18 3.81%
To view Molecule.one’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Molecule.one Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence platform designed for autonomous drug discovery. The company offers an artificia
Discovery Tools (Healthcare)
Portola Valley, CA
37 As of 2026

San Mateo, CA
 

Montreal, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Molecule.one Competitors (14)

One of Molecule.one’s 14 competitors is Genesis Molecular AI, a Venture Capital-Backed company based in San Mateo, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genesis Molecular AI Venture Capital-Backed San Mateo, CA
Chemical Computing Group Private Equity-Backed Montreal, Canada
X-37 Venture Capital-Backed South San Francisco, CA
Exscientia Formerly VC-backed Oxford, United Kingdom
NuMedii Formerly VC-backed San Mateo, CA
You’re viewing 5 of 14 competitors. Get the full list »

Molecule.one Patents

Molecule.one Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025215117-A1 Systems for chemistry tasks based on artificial intelligence methods with improved reasoning using chemistry feedback Pending 10-Apr-2024
CA-3235430-A1 Systems and methods for predicting outcomes and conditions of chemical reactions with high reliability based on a highly diverse and accurate dataset Pending 22-Oct-2021
EP-4420131-A1 Systems and methods for predicting outcomes and conditions of chemical reactions with high reliability based on a highly diverse and accurate dataset Pending 22-Oct-2021
US-20230131234-A1 Systems and methods for predicting outcomes and conditions of chemical reactions with high reliability based on a highly diverse and accurate dataset Pending 22-Oct-2021
WO-2023067202-A1 Systems and methods for predicting outcomes and conditions of chemical reactions with high reliability based on a highly diverse and accurate dataset Inactive 22-Oct-2021 G16C20/10
To view Molecule.one’s complete patent history, request access »

Molecule.one Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Molecule.one Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Standard Industries Corporation
ff Venture Capital Venture Capital Minority
HNVR Technology Investment Management Venture Capital Minority
AME Cloud Ventures Venture Capital Minority
Atmos Ventures Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Molecule.one FAQs

  • When was Molecule.one founded?

    Molecule.one was founded in 2016.

  • Where is Molecule.one headquartered?

    Molecule.one is headquartered in Portola Valley, CA.

  • What is the size of Molecule.one?

    Molecule.one has 37 total employees.

  • What industry is Molecule.one in?

    Molecule.one’s primary industry is Discovery Tools (Healthcare).

  • Is Molecule.one a private or public company?

    Molecule.one is a Private company.

  • What is Molecule.one’s current revenue?

    The current revenue for Molecule.one is .

  • How much funding has Molecule.one raised over time?

    Molecule.one has raised $4.68M.

  • Who are Molecule.one’s investors?

    Standard Industries, ff Venture Capital, HNVR Technology Investment Management, AME Cloud Ventures, and Atmos Ventures are 5 of 16 investors who have invested in Molecule.one.

  • Who are Molecule.one’s competitors?

    Genesis Molecular AI, Chemical Computing Group, X-37, Exscientia, and NuMedii are some of the 14 competitors of Molecule.one.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process